![Achim Plum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Achim Plum
Vorstandsvorsitzender bei
InfanDx AG
Profil
Achim Plum founded aitiologic GmbH in 2023.
Dr. Plum also currently works at InfanDx AG, as Managing Director, Curetis USA, Inc., as Director, and High-Tech Gründerfonds Management GmbH, as Managing Director from 2024.
Dr. Plum also formerly worked at Ares Genetics GmbH, as Co-Managing Director from 2017 to 2020, Epigenomics AG, as SVP-Corporate Development & Investor Relations from 2010 to 2012, and Curetis NV, as Chief Commercial & Business Officer from 2017 to 2018.
Dr. Plum received his graduate degree from the University of East Anglia, doctorate degree in 1999 from the University of Bonn, and undergraduate degree from the University of Bonn.
Aktive Positionen von Achim Plum
| Unternehmen | Position | Beginn |
|---|---|---|
Curetis USA, Inc.
 Curetis USA, Inc. Medical SpecialtiesHealth Technology Manufactures and develops diagnostic instruments | Direktor/Vorstandsmitglied | - |
InfanDx AG
 InfanDx AG Medical/Nursing ServicesHealth Services Develops diagnostics tests for the care of neonates | Vorstandsvorsitzender | 01.01.2021 |
High-Tech Gründerfonds Management GmbH
 High-Tech Gründerfonds Management GmbH Investment ManagersFinance HTGF invests in companies located in Germany. The firm focuses on chemistry, digital tech, industrial tech and life sciences sectors. It participates in pre-seed and seed stage capital requirements with an investment size of EUR 0.8 - 30 million. It makes co-investments, follow-on financing and also acts as a lead investor. | Private Equity Investor | 09.12.2024 |
Ehemalige bekannte Positionen von Achim Plum
| Unternehmen | Position | Ende |
|---|---|---|
Ares Genetics GmbH
 Ares Genetics GmbH Packaged SoftwareTechnology Services Develops artificial intelligence software for DNA sequencing test | Vorstandsvorsitzender | 31.12.2020 |
| EPIGENOMICS AG | Public Communications Contact | 01.10.2012 |
| CURETIS N.V. | Corporate Officer/Principal | - |
Ausbildung von Achim Plum
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
45
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Epigenomics AG
 Epigenomics AG Medical SpecialtiesHealth Technology Engages in the development and commercialization of in vitro diagnostic tests for cancer | Health Technology |
University of East Anglia
 University of East Anglia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bonn
 University of Bonn Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance HTGF invests in companies located in Germany. The firm focuses on chemistry, digital tech, industrial tech and life sciences sectors. It participates in pre-seed and seed stage capital requirements with an investment size of EUR 0.8 - 30 million. It makes co-investments, follow-on financing and also acts as a lead investor. | Finance |
Curetis NV
 Curetis NV Medical/Nursing ServicesHealth Services Develops miniaturized and integrated molecular diagnostic solutions | Health Services |
InfanDx AG
InfanDx AG Medical/Nursing ServicesHealth Services Develops diagnostics tests for the care of neonates | Health Services |
Curetis USA, Inc.
Curetis USA, Inc. Medical SpecialtiesHealth Technology Manufactures and develops diagnostic instruments | Health Technology |
Ares Genetics GmbH
Ares Genetics GmbH Packaged SoftwareTechnology Services Develops artificial intelligence software for DNA sequencing test | Technology Services |
